DUPIXENT (dupilumab injection) is indicated for the treatment of patients aged 12 years and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
DUPIXENT can be used with or without topical corticosteroids.
Click here for additional safety information and for a link to the Product Monograph discussing:
Contraindications: hypersensitivity to DUPIXENT or to any ingredient in the formulation.
Other relevant warnings and precautions regarding: driving or operating machinery; systemic hypersensitivity reactions; live vaccines; conjunctivitis and keratitis; helminth infection; concomitant atopic conditions; pregnant and nursing women; geriatric patients.
Conditions of clinical use, adverse reactions, drug interactions and dosing instructions.